-
June 3, 2023 Lupin Launches Darunavir Tablets in the United States
-
June 1, 2023 Lupin Receives Approval from U.S. FDA for Diazepam Rectal Gel
-
May 31, 2023 Lupin Receives Approval from U.S. FDA for Obeticholic Acid Tablets
-
May 30, 2023 Lupin Announces the Launch of Cetuximab
-
May 26, 2023 Lupin Announces Health Canada Approval of Tiotropium Bromide Inhalation Powder for Treatment of COPD
-
May 25, 2023 Lupin Diagnostics Launches Satellite Laboratory in Vijayawada
-
May 9, 2023 Lupin Q4 FY2023 Results
-
May 5, 2023 Lupin Announces Acquisition of French Pharmaceutical Company Medisol
-
April 12, 2023 Lupin Diagnostics Launches Regional Reference Laboratory in Bengaluru, Strengthening Presence in South India
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications